货号:A449839
同义名:
奥美拉挫
/ H 16868; OMEP
Omeprazole是一种口服活性质子泵抑制剂 (PPI),用于胃肠道疾病研究,IC50 值为 1.1 μM,通过竞争性抑制 CYP2C19 活性,对革兰氏阳性和阴性菌生长具有抑制作用。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | Autophagy ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SBI-0206965 |
+++
ULK1, IC50: 108 nM ULK2, IC50: 711 nM |
95% | |||||||||||||||||
| Hydroxychloroquine sulfate | ✔ | 99% | |||||||||||||||||
| Valproic acid sodium | ✔ | HDAC | 97% | ||||||||||||||||
| PFK-015 |
++
PFKFB3, IC50: 207 nM |
99%+ | |||||||||||||||||
| MRT68921 HCl |
++++
ULK1, IC50: 2.9 nM ULK2, IC50: 1.1 nM |
99%+ | |||||||||||||||||
| ROC-325 | ✔ | 99%+ | |||||||||||||||||
| Autophinib |
+++
Autophagy, IC50: 40 nM |
99% | |||||||||||||||||
| Lys05 | ✔ | 99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 产品名称 | Proton Pump ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zinc pyrithione | ✔ | 98+% | |||||||||||||||||
| PF 03716556 |
++++
H+/K+-ATPase, pIC50: ~6.5 |
99% | |||||||||||||||||
| Lansoprazole | ✔ | 98% | |||||||||||||||||
| Esomeprazole Magnesium | ✔ | 98%+ | |||||||||||||||||
| Rabeprazole | ✔ | 99%+ | |||||||||||||||||
| Ilaprazole | ✔ | TOPK | 97% | ||||||||||||||||
| Bafilomycin A1 |
++++
H+-ATPase, IC50: 0.44 nM |
99% | |||||||||||||||||
| Pantoprazole sodium | ✔ | 98% | |||||||||||||||||
| (R)-Lansoprazole | ✔ | 98% | |||||||||||||||||
| Tenatoprazole | ✔ | 99%+ | |||||||||||||||||
| Omeprazole | ✔ | 98% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | Omeprazole (H 16868), a proton pump inhibitor (PPI), is employed in managing acid-related gastrointestinal conditions. It exhibits competitive inhibition of the CYP2C19 enzyme with a Ki ranging between 2 and 6 μM[1]. Additionally, omeprazole acts as an inhibitor against both Gram-positive and Gram-negative bacteria[2]. Omeprazole also functions as a potent inhibitor of neutral sphingomyelinase (N-SMase), a brain penetrant enzyme involved in exosome regulation[3]. |
| 体外研究 | In clinical use, Omeprazole (H 16868) treats conditions such as dyspepsia, peptic ulcer disease, gastroesophageal reflux disease, laryngopharyngeal reflux, and Zollinger-Ellison syndrome, effectively reducing gastric acid secretion[2]. |
| Administration | Dosage | Frequency | Description | References | ||
| Wistar rats | Two-kidney, one-clip (2K1C) hypertensive model | Intraperitoneal injection | 10 mg/kg | Once daily for four weeks | To evaluate the effect of febuxostat on omeprazole-induced endothelial dysfunction, results showed that febuxostat improved omeprazole-induced impairment in endothelium-dependent vascular responses | Redox Biol. 2016 Oct;9:134-143. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.90mL 0.58mL 0.29mL |
14.48mL 2.90mL 1.45mL |
28.95mL 5.79mL 2.90mL |
|
| CAS号 | 73590-58-6 |
| 分子式 | C17H19N3O3S |
| 分子量 | 345.42 |
| SMILES Code | O=S(C1=NC2=CC=C(OC)C=C2N1)CC3=NC=C(C)C(OC)=C3C |
| MDL No. | MFCD00083192 |
| 别名 | 奥美拉挫 ;H 16868; OMEP; OMZ; OMP |
| 运输 | 蓝冰 |
| InChI Key | SUBDBMMJDZJVOS-UHFFFAOYSA-N |
| Pubchem ID | 4594 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, 2-8°C |
| 溶解方案 |
DMSO: 105 mg/mL(303.98 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1